moderate muscle and joint pain; moderate muscle and joint pain; pain and swelling focused at the injection site; pain and swelling focused at the injection site; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): MDIT22-00132 (Moderna).  A 28 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in deltoid left, administration date 07May2021 (Lot number: FE2707) at the age of 28 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MYALGIA (non-serious), ARTHRALGIA (non-serious) all with onset 07May2021, outcome "recovered" (07May2021) and all described as "moderate muscle and joint pain"; VACCINATION SITE PAIN (non-serious), VACCINATION SITE SWELLING (non-serious) all with onset 07May2021, outcome "recovered" (15May2021) and all described as "pain and swelling focused at the injection site". Therapeutic measures were not taken as a result of myalgia, arthralgia, vaccination site pain, vaccination site swelling.  Additional information: The first two doses of the COVID vaccine were Pfizer: Dose 1 on 07May2021, administered into the left deltoid muscle. No doctor consulted about it. Dose 2 dated 14Aug2021, administered into the right deltoid muscle. Lot FG4686. Reaction: Fever of 39C in the night between 14Aug2021 and 15Aug2021. Brufen treatment 400mg. No doctor consulted about it. No ongoing pregnancy in any of the 3 doses. Patient hereby pointed out the adverse reactions started on 29Jan2022 following the administration of the Pfizer vaccine on 28Jan2022 around 3.30 pm. Patient received third dose of BNT162B2 (PFIZER-BIONTECH m-RNA COVID-19 VACCINE, Solution for injection, Batch number: 216037), administration site: left deltoid muscle. No other information was available in that regard. Event 1: Administration site pain commenced 28Jan2022 (ongoing) no treatment in progress. Event 2: Administration site swelling starting date 28Jan2022 (ongoing) no treatment in progress. Event 3: Swelling of the armpit in the arm of the administration started 28Jan2022 (ongoing) no treatment in progress. Event 4: Severe muscle pain throughout the body. Start date 29Jan2022, end date 30Jan2022. Treatment: 1 tablet of voltaren 100mg prolonged release on 29Jan2022. On medical prescription 1 tablet of brufen 600mg dated 30Jan2022. The event further caused: feeling of tiredness, lack of strength, difficulty walking. Event 5: Severe joint pain in all joints of the body. Start date 29Jan2022, end date 30Jan2022. Treatment: 1 tablet of voltaren 100mg prolonged release on 29Jan2022. On medical prescription. 1 tablet of brufen 600mg dated 30Jan2022. The event caused further: difficulties in movements. Event 6 - Persistent fever at 40C throughout the night of 29Jan2022 despite the voltaren tablet. The event further caused episodes of delirium due to fever lasting no more than 30 minutes. The event began and ended on the night of 29Jan2022. Event 7: Diarrhea. Started on the night of 29Jan2022 (ongoing) no treatment in progress. Event 8: Pain in the cervical and lumbar area (unclear if purely muscular in nature). Insurgents on the night of 29Jan2022 ended 30Jan2022. Brufen 609mg treatment prescribed by your GP. The reactions following the third dose have already been reported to the competent authorities today. Patient was available for any clarification. Treatment 1 tablet of voltaren 100mg prolonged release on 29Jan2022. On medical prescription 1 tablet of brufen 600mg dated 30Jan2022.  No follow-up attempts are possible. No further information is expected.